These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 29055286)
21. Changes in the lipoprotein profile in postmenopausal women receiving hormone replacement therapy. Effects of natural and synthetic progesterone. Chen FP; Lee N; Soong YK J Reprod Med; 1998 Jul; 43(7):568-74. PubMed ID: 9693406 [TBL] [Abstract][Full Text] [Related]
22. Are the progestins responsible for breast cancer risk during hormone therapy in the postmenopause? Experimental vs. clinical data. Seeger H; Mueck AO J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):11-5. PubMed ID: 18206365 [TBL] [Abstract][Full Text] [Related]
23. Progesterone, progestins, and the heart. Bernstein P; Pohost G Rev Cardiovasc Med; 2010; 11(3):e141-9. PubMed ID: 21045766 [TBL] [Abstract][Full Text] [Related]
24. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival. Menendez JA; Oza BP; Colomer R; Lupu R Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863 [TBL] [Abstract][Full Text] [Related]
25. [Effects of progesterone and progestational hormones on the mammary gland]. Gorins A; Denis C Arch Anat Cytol Pathol; 1995; 43(1-2):28-35. PubMed ID: 7794024 [TBL] [Abstract][Full Text] [Related]
26. [Hormone replacement therapy in menopause and risk of breast cancer]. Clavel-Chapelon F; Hill C Presse Med; 2000 Oct; 29(31):1688-93. PubMed ID: 11094609 [TBL] [Abstract][Full Text] [Related]
27. Progesterone, progestins, and the heart. Bernstein P; Pohost G Rev Cardiovasc Med; 2010; 11(4):228-36. PubMed ID: 21389912 [TBL] [Abstract][Full Text] [Related]
28. Micronized progesterone and its impact on the endometrium and breast vs. progestogens. Gompel A Climacteric; 2012 Apr; 15 Suppl 1():18-25. PubMed ID: 22432812 [TBL] [Abstract][Full Text] [Related]
29. Evidence on the use of progesterone in menopausal hormone therapy. Mirkin S Climacteric; 2018 Aug; 21(4):346-354. PubMed ID: 29630427 [TBL] [Abstract][Full Text] [Related]
30. Progestins and breast cancer risk. Campagnoli C; Biglia N; Giai M; Sismondi P Zentralbl Gynakol; 1997; 119 Suppl 2():38-42. PubMed ID: 9361393 [TBL] [Abstract][Full Text] [Related]
31. Comparative cardiovascular effects of different progestins in menopause. Rosano GM; Fini M Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197 [TBL] [Abstract][Full Text] [Related]
32. Estrogen, androgen, glucocorticoid, and progesterone receptors in progestin-induced regression of human breast cancer. Teulings FA; van Gilse HA; Henkelman MS; Portengen H; Alexieva-Figusch J Cancer Res; 1980 Jul; 40(7):2557-61. PubMed ID: 6248208 [TBL] [Abstract][Full Text] [Related]
33. Breast cancer risk with postmenopausal hormonal treatment. Collins JA; Blake JM; Crosignani PG Hum Reprod Update; 2005; 11(6):545-60. PubMed ID: 16150813 [TBL] [Abstract][Full Text] [Related]
34. Progestin-mediated activation of MAPK and AKT in nuclear progesterone receptor negative breast epithelial cells: The role of membrane progesterone receptors. Salazar M; Lerma-Ortiz A; Hooks GM; Ashley AK; Ashley RL Gene; 2016 Oct; 591(1):6-13. PubMed ID: 27349565 [TBL] [Abstract][Full Text] [Related]
35. Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy--long-term follow-up of a Swedish cohort. Persson I; Yuen J; Bergkvist L; Schairer C Int J Cancer; 1996 Jul; 67(3):327-32. PubMed ID: 8707404 [TBL] [Abstract][Full Text] [Related]
36. Cardiovascular effects of medroxyprogesterone acetate and progesterone: a case of mistaken identity? Hermsmeyer RK; Thompson TL; Pohost GM; Kaski JC Nat Clin Pract Cardiovasc Med; 2008 Jul; 5(7):387-95. PubMed ID: 18521110 [TBL] [Abstract][Full Text] [Related]
37. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. Colditz GA; Hankinson SE; Hunter DJ; Willett WC; Manson JE; Stampfer MJ; Hennekens C; Rosner B; Speizer FE N Engl J Med; 1995 Jun; 332(24):1589-93. PubMed ID: 7753136 [TBL] [Abstract][Full Text] [Related]
38. Progestins in the menopause in healthy women and breast cancer patients. Pasqualini JR Maturitas; 2009 Apr; 62(4):343-8. PubMed ID: 19179024 [TBL] [Abstract][Full Text] [Related]
39. Progestogens in postmenopausal hormone therapy and the risk of breast cancer. Lambrinoudaki I Maturitas; 2014 Apr; 77(4):311-7. PubMed ID: 24485796 [TBL] [Abstract][Full Text] [Related]
40. Molecular mechanisms of steroid receptor-mediated actions by synthetic progestins used in HRT and contraception. Africander D; Verhoog N; Hapgood JP Steroids; 2011 Jun; 76(7):636-52. PubMed ID: 21414337 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]